American Radium Society Appropriate Use Criteria for the use of liverdirected therapies for nonsurgical management of liver metastases: Systematic review and …
CL Hallemeier, N Sharma, C Anker, JE Selfridge… - Cancer, 2023 - Wiley Online Library
The liver is a common site of cancer metastases. Systemic therapy is widely accepted as the
standard treatment for liver metastases (LM), although select patients with liver …
standard treatment for liver metastases (LM), although select patients with liver …
A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases
K Kim, JI Yu, HC Park, GS Yoo, DH Lim, JM Noh… - Radiotherapy and …, 2022 - Elsevier
Background and purpose Proton beam therapy (PBT) is an effective treatment option for
primary malignant liver disease. However, evidence regarding liver metastasis is insufficient …
primary malignant liver disease. However, evidence regarding liver metastasis is insufficient …
Effectiveness of proton beam therapy for liver oligometastatic recurrence in patients with postoperative esophagus cancer
H Yamaguchi, T Kato, M Honda… - Journal of Radiation …, 2023 - academic.oup.com
There are several reports of hepatic resection for postoperative hepatic metastatic
recurrence of esophageal cancer. However, it is unclear whether surgery is the best local …
recurrence of esophageal cancer. However, it is unclear whether surgery is the best local …
The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in breast cancer patients
H Yamaguchi, N Fukumitsu, H Numajiri… - Journal of Radiation …, 2024 - academic.oup.com
A nationwide multicenter cohort study on particle therapy was launched by the Japanese
Society for Radiation Oncology in Japan in May 2016. We analyzed the outcome of proton …
Society for Radiation Oncology in Japan in May 2016. We analyzed the outcome of proton …
[HTML][HTML] Preliminary Investigation of the Efficacy and Indications of Proton Beam Therapy for Stage IV Pancreatic Adenocarcinoma
H Yamaguchi, T Kato, Y Narita, M Honda, K Hamada… - Cureus, 2024 - ncbi.nlm.nih.gov
Background: The present study aimed to evaluate proton beam therapy (PBT) for stage IV
pancreatic adenocarcinoma and its metastases and define the criteria for eligibility …
pancreatic adenocarcinoma and its metastases and define the criteria for eligibility …
Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma
Simple Summary Proton beam therapy (PBT) has the potential to improve local tumor control
and subsequently improve survival of patients with inoperable or recurrent intrahepatic …
and subsequently improve survival of patients with inoperable or recurrent intrahepatic …
The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in breast cancer patients
H Yamaguchi, N Fukumitsu, H Numajiri… - International Journal of …, 2023 - redjournal.org
Purpose/Objective (s) A nationwide multicenter cohort study on particle therapy was
launched by the Japanese Society for Radiation Oncology (JASTRO) in Japan. We analyzed …
launched by the Japanese Society for Radiation Oncology (JASTRO) in Japan. We analyzed …
陽子線治療により2 年間局所制御されている乳癌オリゴ肺転移の1 例
山村和生， 宮嶋則行， 岡崎泰士， 田中健太… - 日本臨床外科学会 …, 2023 - jstage.jst.go.jp
抄録 症例は 48 歳, 女性. 42 歳時, 右乳癌に対し乳房部分切除術とセンチネルリンパ節生検を施行
(pT1c, pN0, cM0, ER 陰性, PgR 陰性, HER2 陰性, Ki67 70%). 術後補助療法として EC 療法 4 …
(pT1c, pN0, cM0, ER 陰性, PgR 陰性, HER2 陰性, Ki67 70%). 術後補助療法として EC 療法 4 …